First Investigational All Injectable Long Acting HIV Combination Regimen Study Results at 32 Weeks Announced
Cork, Ireland (ots/PRNewswire) - Injectable combinations once every 4 or 8 weeks show comparable efficacy versus daily oral combination therapy Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced that Phase IIb data studying a combination regimen of ...